Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22,421,536
-
Total 13F shares
-
11,605,942
-
Share change
-
+4,429,037
-
Total reported value
-
$70,001,654
-
Put/Call ratio
-
53%
-
Price per share
-
$6.03
-
Number of holders
-
78
-
Value change
-
+$25,580,086
-
Number of buys
-
51
-
Number of sells
-
32
Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q4 2022
As of 31 Dec 2022,
CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,605,942 shares.
The largest 10 holders included
CITADEL ADVISORS LLC, Bill & Melinda Gates Foundation, Balyasny Asset Management LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, MARSHALL WACE, LLP, PRICE T ROWE ASSOCIATES INC /MD/, NORGES BANK, MORGAN STANLEY, and STATE STREET CORP.
This page lists
78
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.